Stocksigma LogoStocksigma Logo

Medicamen Organics Reports Zero Deviation in Preferential Issue Fund Utilization

Medicamen Organics Limited reported no deviation or variation in the utilization of funds raised via its preferential allotment of equity shares and

Medicamen Organics Reports Zero Deviation in Preferential Issue Fund Utilization

Medicamen Organics Ltd 路 Others (Uncategorized) 路 15 Nov 2026, 3:58 am

Medicamen Organics Reports Zero Deviation in Preferential Issue Fund Utilization Medicamen Organics Limited reported no deviation or variation in the utilization of funds raised via its preferential allotment of equity shares and convertible warrants for the half-year ended 30th Sep'26. Against total targeted proceeds of INR 13.65 cr, the company received INR 12.29 cr, with INR 1.36 cr pending on outstanding warrants. Of the received proceeds, INR 10.92 cr has been utilized鈥擨NR 8.80 cr for working capital and INR 2.12 cr for general corporate purposes鈥攍eaving INR 1.36 cr unutilized in designated bank accounts.

Original exchange filing (PDF)

More announcements from Medicamen Organics Ltd

All Medicamen Organics Ltd announcements